An interventional study of Momelan Technologies Epidermal Graft Harvesting System in Neoplasm of Skin, sponsored by Momelan Technologies. Status unknown at 1 site in United States. Open to participants aged 35 Years to 90 Years. Per ClinicalTrials.gov, last updated 2012-02-22.
Sponsored by Momelan Technologies · Not applicable, Interventional, and Treatment
This case series will assess the use of suction blister epidermal grafts harvested by a novel device on select patients that have wounds from Mohs or excisional surgery.
This study evaluates a novel micrografting technique to determine how it will influence the healing and cosmetic result of selected post surgical wounds in 12 subjects. The Epidermal Expansion System (designed by MoMelan Technologies) will generate an array of small microblisters and transfer the micrografts to a sterile wound dressing for application to the subject's surgical area. The sponsor hypothesizes that applying expanded micrografts to wounds that otherwise would have healed by second intention alone will hasten healing and possibly reduce scarring.
582 studies on the registry are indexed under Skin Neoplasms; 114 are open to participants now.
This study's planned enrollment of 12 is below the median of 53 across 416 interventional studies indexed under Skin Neoplasms.
Browse Skin Neoplasms studies →Momelan Technologies is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: Momelan Technologies Epidermal Graft Harvesting System
The procurement of the epidermal micrograft involves the use of the MoMelan Technologies suction blister system which consists of a control box that creates the vacuum necessary to create the microblisters and a harvester. The device is applied to the subject's thigh to create blisters. The epidermal micrografts are then harvested and transferred to Tegaderm™ and then placed on the surgical wound and the wound is bandaged.
Wound healing/scarring
Time frame: 6 weeks
Incidence of adverse events
Time frame: 6 weeks
Physician global satisfaction
Time frame: 6 weeks
Subject global satisfaction
Time frame: 6 weeks
This study is status unknown, as verified in Feb 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Momelan Technologies